APA način citiranja

Fazekas, F., Bajenaru, O., Berger, T., Fabjan, T. H., Ledinek, A. H., Jakab, G., . . . Havrdová, E. (2013). How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis? Frontiers Media S.A.

Čikaški stil citiranja

Fazekas, Franz, et al. How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis? Frontiers Media S.A, 2013.

MLA način citiranja

Fazekas, Franz, et al. How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis? Frontiers Media S.A, 2013.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.